Your browser doesn't support javascript.
loading
Inappropriate use of proton pump inhibitors in hospitalized patients with lower gastrointestinal bleeding.
Quinn, Andrew J; Saven, Hannah; Haile, Rozina; Moon, Seung Jae; Lee, April; Thor, Savanna.
Afiliação
  • Quinn AJ; Department of Medicine, Division of Gastroenterology, SUNY Downstate Health Science University, Brooklyn, NY, USA.
  • Saven H; Department of Medicine, Division of Gastroenterology, SUNY Downstate Health Science University, Brooklyn, NY, USA.
  • Haile R; Department of Medicine, Division of Gastroenterology, SUNY Downstate Health Science University, Brooklyn, NY, USA.
  • Moon SJ; Department of Medicine, Division of Gastroenterology, SUNY Downstate Health Science University, Brooklyn, NY, USA.
  • Lee A; Department of Medicine, Division of Gastroenterology, SUNY Downstate Health Science University, Brooklyn, NY, USA.
  • Thor S; Department of Medicine, Division of Gastroenterology, SUNY Downstate Health Science University, Brooklyn, NY, USA.
Hosp Pract (1995) ; 52(1-2): 19-22, 2024.
Article em En | MEDLINE | ID: mdl-38407180
ABSTRACT

OBJECTIVES:

Use of proton pump inhibitors (PPIs) is a mainstay in treating upper gastrointestinal bleeding (UGIB). However, the beneficial effects of PPIs are not anticipated to extend beyond the duodenum and may actually contribute to the risk of lower gastrointestinal bleeding (LGIB). However, in practice, PPIs are often used for inpatients with LGIB where no benefit exists.

METHODS:

A retrospective chart review was performed on inpatients during a 2-year period at an urban academic teaching hospital. Inpatients with consults to the gastroenterology (GI) service with confirmed or highly suspected LGIB were included. Outcomes regarding PPI use and the GI consulting service recommendations in these 225 patients were evaluated.

RESULTS:

About 37.8% of patients were started on a PPI during their inpatient course. Of those, 46% patients started on a PPI had no indication for PPI and 85% had no recommendation by the GI consultants to start a PPI. Of the 85 patients started on PPI, the GI consultants recommended stopping it in two (2.3%) patients. Lastly, 20 patients (9%) were discharged on PPI without an indication for PPI.

CONCLUSION:

To our knowledge, this is the first study that looked at the inappropriate utilization of PPIs in patients admitted for LGIBs utilizing GI consultant recommendations. Given the large proportion of patients started on PPI without a clinical indication and continued at discharge and the paucity of GI recommendations to discontinue inappropriate use, we found that clinical care may be improved with formal GI recommendations regarding use of PPI.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Bomba de Prótons / Prescrição Inadequada / Hemorragia Gastrointestinal Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Bomba de Prótons / Prescrição Inadequada / Hemorragia Gastrointestinal Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article